Navinta LLC FDA Inspection Record
Navinta LLC is an FDA-registered facility (FEI 3004375014) located in Ewing, NJ, US. Registered operations: ANALYSIS; API MANUFACTURE. RegDataLab tracks 6 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Sep 30, 2024: No Action Indicated (NAI)
- Inspections on record
- 6 (1 OAI, 2 VAI, 3 NAI)
- Last OAI inspection
- May 16, 2016
- Warning letters
- 1 listed by FDA for this FEI, latest Sep 26, 2016
- Recalls as the recalling firm
- 1, latest Mar 9, 2015
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Sep 30, 2024 | No Action Indicated (NAI) | No citations listed |
| May 4, 2023 | No Action Indicated (NAI) | No citations listed |
| Mar 28, 2019 | Voluntary Action Indicated (VAI) | Failure to submit scientific article (21 CFR 314.80(d)) |
| Aug 18, 2017 | Voluntary Action Indicated (VAI) | Late submission of an ICSR (21 CFR 314.80(c)(2)(ii)(B)) Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) Incomplete periodic safety report (21 CFR 314.80(c)(2)(ii)(A)) Failure to maintain records (21 CFR 314.80(j)) |
| May 16, 2016 | Official Action Indicated (OAI) | Failure to develop written procedures (21 CFR 314.80(b)) Interval (21 CFR 314.80(c)(2)) Timely submission (21 CFR 314.81(b)(2)) |
| Aug 10, 2015 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Mar 9, 2015 | Class II | D-0431-2015 | Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only… Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility. |
FDA record score
3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
5 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Mar 28, 2019 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Aug 18, 2017 | 6 x 0.25 | 1.5 |
| Warning letter on FDA's dashboard, which does not show close-outs | Sep 26, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | May 16, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0431-2015, this FEI as the recalling firm | Mar 9, 2015 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Navinta LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Navinta LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Navinta, LLC
- Location
- Ewing, NJ (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; API MANUFACTURE
- Source
- decrs